Project Grant K01DK147652
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $5.67 million Project Grant to the University of California, San Diego on September 15, 2025, with a completion date of September 14, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research investigating renal metabolism changes in sepsis-associated acute kidney injury (AKI), with a focus on...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $145,648 to Indiana University Indianapolis on June 19, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a predoctoral research training and career development project. The award supports a National Research Service Award (NRSA) tailored to doctoral candidate Ms. Hibbard, providing high-quality mentored research training through...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $786,216 Project Grant to the University of California, Los Angeles (UCLA) on August 28, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a four-year research initiative (through June 30, 2029) investigating post-transcriptional regulation of hepatokines and systemic metabolism. The research focuses on identifying...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Regents of the University of California, San Francisco a Project Grant of $790,063 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective March 1, 2026, with completion targeted for December 31, 2030. The award funds research to functionally characterize and classify pathogenic missense mutations in polycystin-1 (PC1), a protein...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant totaling $155,562 to Stony Brook University (operating through The Research Foundation For The State University Of New York) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, dated December 11, 2025, supports research investigating alterations of branched chain amino acid (BCAA) catabolism in acute kidney injury...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $373,088 to the University of California, San Diego under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on July 15, 2025. This five-year Project Grant (through June 30, 2030) supports a T32 Multidisciplinary Research Training program in Digestive Physiology and Diseases designed to train postdoctoral researchers in advanced biomedical...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $201,084 Project Grant to Albert Einstein College of Medicine on February 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This K23 career development award supports Dr. Molly Fisher's research into the role of inflammation and senescence in kidney injury among people with HIV (PWH). The project, scheduled for completion by...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University a Project Grant totaling $1,491,303 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period September 5, 2025, through September 4, 2029. This award supports basic biomedical research investigating the molecular mechanisms that drive progression from acute kidney injury (AKI) to chronic kidney...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of California, Irvine a $229,553 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) beginning September 1, 2025, and concluding August 31, 2027. This mixed-methods research study will investigate non-clinical donor factors affecting post-donation follow-up care for living kidney donors and evaluate telemedicine...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Children's Hospital of Philadelphia Research Institute a $343,278 Project Grant (CFDA 93.847: Diabetes, Digestive, and Kidney Diseases Extramural Research) effective July 16, 2025, through March 31, 2030. This award funds a multi-omic investigation of uremic toxin sources and accumulation in children with kidney failure, specifically comparing children with chronic kidney...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $148,596 to the University of California, San Diego through the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on June 1, 2026, for a five-year project period concluding May 31, 2031. This K01 career development award supports Dr. Armin Ahmadi's research investigating cell-free mitochondrial DNA (CF-mtDNA) as a biomarker of kidney and vascular dysfunction in chronic kidney disease (CKD), with evaluation of nicotinamide riboside as a potential therapeutic intervention. The project directly advances NIDDK's mission to support biomedical research improving understanding and treatment of kidney diseases and related metabolic disorders. Under this award, Dr. Ahmadi will establish himself as an independent investigator through structured mentorship, advanced coursework, and workshops while conducting patient-oriented research. Key deliverables include developing proficiency in CF-mtDNA measurement and noninvasive microvascular assessment techniques, gaining expertise in advanced statistical methods for clinical trials, and designing and leading independent clinical research. The research team comprises multidisciplinary experts including a primary mentor in clinical trials, co-mentors specializing in nephrology and mitochondrial biology, and a biostatistician, collectively addressing the scientific gap that current CKD biomarkers provide limited insight into disease progression and vascular dysfunction.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $148.6k | 5/28/26 |